BioWorld MedTech

June 14, 2018

FDA approves Wright's injectable bone graft

Wright Medical Group NV won FDA approval for its Augment injectable bone graft. As a result, the company plans to update its 2018 guidance on its second quarter earnings call. Read More

Vergent raises $8.7M series A to develop fluorescent solid tumor surgical probe

FDA takes another crack at commercial speech controversy

Singapore changes medical device requirements for faster market access

Brain sleepiness signature, links to memory identified

Other news to note

Daily M&A

Regulatory front

Appointments and advancements

Product briefs

Financings

BioWorld MedTech's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 14, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 13, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld MedTech

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...